Floatz logo

117 assets in Colorectal Neoplasm

Therapeutic assets addressing Colorectal Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
esg401
Colorectal Neoplasm
Shanghai Escugen Biotechnology Co., LtdP1/2CCC (52)
Pertuzumab
Colorectal Neoplasm
Cancer Research UKP2/3CCC (52)
Balstilimab
Colorectal Neoplasm
Weill Medical College of Cornell UniversityP2CCC (51)
Botensilimab
Colorectal Neoplasm
Weill Medical College of Cornell UniversityP2CCC (51)
Dexasone
Colorectal Neoplasm
National Cancer Institute (NCI)P2CCC (51)
Disitamab Vedotin
Colorectal Neoplasm
The First Affiliated Hospital with Nanjing Medical UniversityP2CCC (51)
Durvalumab
Colorectal Neoplasm
University of IowaP1/2CCC (51)
e7386
Colorectal Neoplasm
Eisai Inc.P1/2CCC (51)
Encorafenib
Colorectal Neoplasm
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP2CCC (51)
Envafolimab
Colorectal Neoplasm
First Affiliated Hospital Xi'an Jiaotong UniversityP2CCC (51)
Gm-Csf
Colorectal Neoplasm
The First Affiliated Hospital of Xiamen UniversityP2CCC (51)
Immunoglobulin G1, Anti-(Human Epidermal Growth Factor Receptor Her2) (Human-Mus Musculus Monoclonal Shr-1805 ?1-Chain), Complex With Human-Mus Musculus Monoclonal Shr-1805 ?-Chain, Dimer, Thioether With N-[6-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-1-Oxohexyl]Glycylglycyl-L-Phenylalanyl-N-[[(1R)-1-Cyclopropyl-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-2-Oxoethoxy]Methyl]Glycinamide
Colorectal Neoplasm
Haihua YuanP2CCC (51)
Metformin
Colorectal Neoplasm
University of EdinburghP2CCC (51)
Nocardia Rubra Cell Wall Skeleton
Colorectal Neoplasm
Sun JingP2CCC (51)
pds01adc
Colorectal Neoplasm
National Cancer Institute (NCI)P2CCC (51)
Surufatinib
Colorectal Neoplasm
Hubei Cancer HospitalP2CCC (51)
Tisotumab Vedotin
Colorectal Neoplasm
Seagen, a wholly owned subsidiary of PfizerP2CCC (51)
Tuvonralimab
Colorectal Neoplasm
Peking University Cancer Hospital & InstituteP2CCC (51)
Vemurafenib
Colorectal Neoplasm
Cancer Research UKP2/3CCC (51)
Zanidatamab
Colorectal Neoplasm
Haihua YuanP2CCC (51)
Elraglusib
Colorectal Neoplasm
Actuate Therapeutics Inc.P2CCC (50)
Fosifloxuridine Nafalbenamide
Colorectal Neoplasm
NuCana plcP2CCC (49)
gsk4418959
Colorectal Neoplasm
GlaxoSmithKlineP1/2CCC (48)
gsk5460025
Colorectal Neoplasm
GlaxoSmithKlineP1/2CCC (48)
Aspirin
Colorectal Neoplasm
University of Michigan Rogel Cancer CenterEarly P1CC (47)
a2b530
Colorectal Neoplasm
A2 Biotherapeutics Inc.P1/2CC (43)
Blu-924
Colorectal Neoplasm
Blueprint Medicines CorporationP1/2CC (43)
Cediranib
Colorectal Neoplasm
National Cancer Institute (NCI)P1/2CC (43)
Claudin18.2-Targeted Car-Dcs
Colorectal Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1CC (43)
Claudin18.2-Targeted Car-T Cells
Colorectal Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1CC (43)
Fludarabine
Colorectal Neoplasm
TCR2 TherapeuticsP1/2CC (43)
htl0039732 capsules
Colorectal Neoplasm
Cancer Research UKP1/2CC (43)
Nadravaleucel
Colorectal Neoplasm
NKGen Biotech, Inc.P1/2CC (43)
Olaparib
Colorectal Neoplasm
National Cancer Institute (NCI)P1/2CC (43)
Olomorasib
Colorectal Neoplasm
Eli Lilly and CompanyP1/2CC (43)
Omeprazole
Colorectal Neoplasm
University of Michigan Rogel Cancer CenterEarly P1CC (43)
Opnurasib
Colorectal Neoplasm
Novartis PharmaceuticalsP1/2CC (43)
Petiveria Alliacea Preparation
Colorectal Neoplasm
Hospital Universitario San IgnacioP1/2CC (43)
Raltitrexed
Colorectal Neoplasm
China Medical University, ChinaP1/2CC (43)
Ribociclib
Colorectal Neoplasm
Novartis PharmaceuticalsP1/2CC (43)
tc-510
Colorectal Neoplasm
TCR2 TherapeuticsP1/2CC (43)
ucb4594
Colorectal Neoplasm
Cancer Research UKP1/2CC (43)
Arry-558
Colorectal Neoplasm
PfizerP1C (39)
azd9592
Colorectal Neoplasm
AstraZenecaP1C (39)
dm002
Colorectal Neoplasm
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.P1C (39)
Itraconazole
Colorectal Neoplasm
Eli Lilly and CompanyP1C (39)
Jnj-89402638
Colorectal Neoplasm
Janssen Research & Development, LLCP1C (39)
Jnj-95437446
Colorectal Neoplasm
Janssen Research & Development, LLCP1C (39)
Lithium, Elemental
Colorectal Neoplasm
Cancer Trials IrelandP1C (39)
ly4170156
Colorectal Neoplasm
Eli Lilly and CompanyP1C (39)
Showing 51 to 100 of 117 assets
PreviousPage 2 of 3Next